HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Dietary Supplements Wellness

Industry Roundup: Puerto Rico Supplements Rule, Lunada-FTC Settlement

This article was originally published in The Tan Sheet

  • News

Executive Summary

Economax warned on spiked supplement; ASA rejects acupressure immediate relief claim; CRN cautions on folate/autism study findings; and more news in brief.

You may also be interested in...



Supplement Claims Targeting Elderly, Weight Conscious Top FTC Priorities

Dubious supplement ad claims that have driven FTC enforcement in the sector for some time likely will continue as three commission seats are filled, says advertising practices official Richard Cleland.

NutraClick 'Free' Offer Curbed: Health And Wellness Industry News Roundup

Organic group updates global business guide; FTC doesn't split hairs on Coorga claim; social media etiquette lesson for UK nutritionals firm; and more news in brief.

What’s Next? Five Things To Look Out For In October

Generics Bulletin previews the most notable and anticipated events for October 2023.

Table

View full table

Topics

Related Companies

Tags:
Dietary Supplements Wellness
Latest Headlines

US Health And Wellness Executive Decisions: Perrigo, Nestle, Flexpower Health, Herbalife, More

FDA’s OTC Monograph User Fees Are Existential Threat To Small Contract Manufacturers, Cosmetics Brands

ECHA Committees Get Started On PFAS Opinions, Armed With More Than 5,600 Comments

‘The Power Of Persuasion’: FDA Ombudsman Discusses Her Role

See All
UsernamePublicRestriction

Register

RS108906

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By